779 related articles for article (PubMed ID: 3830064)
1. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
[TBL] [Abstract][Full Text] [Related]
2. Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction.
Pavlik EJ; van Nagell JR; Nelson K; Gallion H; Donaldson ES; Kenady DE; Baranowska-Kortylewicz J
Endocrinology; 1986 May; 118(5):1924-34. PubMed ID: 2422013
[TBL] [Abstract][Full Text] [Related]
3. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
4. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate.
Borgna JL; Scali J
J Steroid Biochem; 1988 Oct; 31(4A):427-36. PubMed ID: 3050278
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
Attardi B; Happe HK
Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen.
Monsma FJ; Katzenellenbogen BS; Miller MA; Ziegler YS; Katzenellenbogen JA
Endocrinology; 1984 Jul; 115(1):143-53. PubMed ID: 6734512
[TBL] [Abstract][Full Text] [Related]
7. Hydrodynamic characterizations of estrogen receptors complexed with [3H]-4-hydroxytamoxifen: evidence in support of contrasting receptor transitions mediated by different ligands.
Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Hanson MB; Gallion H; Flanigan RC; Kenady DE
Biochemistry; 1985 Dec; 24(27):8101-6. PubMed ID: 4092059
[TBL] [Abstract][Full Text] [Related]
8. Interaction of estradiol and estriol with uterine estrogen receptor in vivo and in excised uteri or cell suspensions at 37 C: noncooperative estradiol binding and absence of estriol inhibition of estradiol-induced receptor activation and transformation.
Müller RE; Traish AM; Wotiz HH
Endocrinology; 1985 Nov; 117(5):1839-47. PubMed ID: 4042965
[TBL] [Abstract][Full Text] [Related]
9. Ligand-receptor dissociation: a potential mechanism for the attenuation of estrogen action in the juvenile rabbit uterus.
Chilton BS; Williams ND; Cobb AD; Leavitt WW
Endocrinology; 1987 Feb; 120(2):750-7. PubMed ID: 3803303
[TBL] [Abstract][Full Text] [Related]
10. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
[TBL] [Abstract][Full Text] [Related]
11. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
Dix CJ; Jordan VC
Endocrinology; 1980 Dec; 107(6):2011-20. PubMed ID: 7191796
[TBL] [Abstract][Full Text] [Related]
12. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
Ruh TS; Baudendistel LJ
Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
[TBL] [Abstract][Full Text] [Related]
13. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
Pavlik EJ; Nelson K; Srinivasan S; Powell DE; Kenady DE; DePriest PD; Gallion HH; van Nagell JR
Cancer Res; 1992 Aug; 52(15):4106-12. PubMed ID: 1638522
[TBL] [Abstract][Full Text] [Related]
14. Effect of aging on the dissociation kinetics and estradiol receptor nuclear interactions in mouse uteri: correlation with biological effects.
Belisle S; Bellabarba D; Lehoux JG; Robel P; Baulieu EE
Endocrinology; 1986 Feb; 118(2):750-8. PubMed ID: 3943490
[TBL] [Abstract][Full Text] [Related]
15. Activation of [3H]estradiol--and [3H]H1285-receptor complexes: effect of salt versus ATP on molybdate-stabilized estrogen receptors.
Singh RK; Ruh MF; Ruh TS
J Steroid Biochem; 1984 Aug; 21(2):205-8. PubMed ID: 6482431
[TBL] [Abstract][Full Text] [Related]
16. High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite.
Borgna JL; Rochefort H
Mol Cell Endocrinol; 1980 Oct; 20(1):71-85. PubMed ID: 7439523
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a unique population of unfilled estrogen-binding sites associated with the nuclear fraction of immature rat uteri.
Carlson RA; Gorski J
Endocrinology; 1980 Jun; 106(6):1776-85. PubMed ID: 7371593
[TBL] [Abstract][Full Text] [Related]
18. Progesterone action in hamster uterus: rapid inhibition of 3H-estradiol retention by the nuclear fraction.
Evans RW; Leavitt WW
Endocrinology; 1980 Oct; 107(4):1261-3. PubMed ID: 7408773
[TBL] [Abstract][Full Text] [Related]
19. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
[TBL] [Abstract][Full Text] [Related]
20. Effects of sulfhydryl reagents on uterine nuclear estrogen receptors labeled by in vitro exchange with [3H]estradiol or [3H]4-hydroxytamoxifen.
Attardi B
J Recept Res; 1984; 4(7):787-800. PubMed ID: 6527361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
